Enasidenib
An orally available, selective, potent inhibitor of mutant IDH2 with IC50s of 100-400 nM for IDH2R140Q homodimer.
Product Specifications
CAS Number
1446502-11-9
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
473.375
Molecular Formula
C19H17F6N7O
Notes
Research use only, not for human use.
Receptor
IDH2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
I8430-02F-ML550 100 µL
IL8, CT (Interleukin-8, IL-8, C-X-C Motif Chemokine 8, Monocyte-derived Neutrophil Chemotactic Factor, MDNCF, T-cell Chemotactic Factor, Neutrophil-activating Protein 1, NAP-1, Protein 3-10C, Granulocyte Chemotactic Protein 1, GCP-1, Monocyte-derived Neutrophil-activating Peptide, MONAP, Emoctakin, CXCL8, IL8) (MaxLight 550) discontinued
Ask
View Details 
MBS2709627-01 24 Strip Well
Human Epidermal Growth Factor Receptor (EGFR)(Sandwich ELISA) ELISA Kit
Ask
View Details MBS2709627-02 48 Well
Human Epidermal Growth Factor Receptor (EGFR)(Sandwich ELISA) ELISA Kit
Ask
View Details MBS2709627-03 96 Well
Human Epidermal Growth Factor Receptor (EGFR)(Sandwich ELISA) ELISA Kit
Ask
View Details MBS2709627-04 5x 96 Well
Human Epidermal Growth Factor Receptor (EGFR)(Sandwich ELISA) ELISA Kit
Ask
View Details